Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00254670 · ClinicalTrials.gov registry record · NA
Naltrexone Effects on Alcohol Intake
A NA study of Social Drinker, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 1
- Study location
NCT00254670: Completed NA study of Social Drinker, sponsored by University of California, San Francisco.
NCT00254670 is a NA study of Social Drinker that has completed, run by University of California, San Francisco. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00254670, a NA study of Social Drinker, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 1
- Study location
Study Summary
The purpose of this study is to examine drinking behavior and decision-making while taking Naltrexone and placebo. This is a double-blind, randomized, placebo-controlled crossover study. There are two cycles: one cycle on Naltrexone and one cycle on placebo.
Conditions Studied
Interventions
- DRUG Naltrexone
Study Locations (1)
California
- UCSF - San Francisco
Trial Details
| Field | Value |
|---|---|
| Start Date | 2005-02 |
| Est. Completion | 2006-12 |
| Phase | NA |
What the finished NCT00254670 record still lists
NCT00254670 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 1 condition, with Social Drinker appearing as the primary indexed condition, and to 1 intervention - of which Naltrexone is the first listed.
NCT00254670 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT00254670 about?
NCT00254670 is a clinical study titled "Naltrexone Effects on Alcohol Intake". The purpose of this study is to examine drinking behavior and decision-making while taking Naltrexone and placebo. This is a double-blind, randomized, placebo-controlled crossover study. There are two cycles: one cycle on Naltrexone and one cycle on placebo.
What is the current status of trial NCT00254670?
This trial is currently completed. It is a NA study. The study started on 2005-02. Estimated completion is 2006-12.
What conditions does trial NCT00254670 study?
This clinical trial studies the following conditions: Social Drinker.
What interventions are being tested in trial NCT00254670?
The interventions under investigation include: Naltrexone (DRUG).
Who is sponsoring clinical trial NCT00254670?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00254670 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia